The 2023 Avicenna Days will bring together regulators, scientists, researchers, industry and academia leaders to update the entire healthcare community on recent progress and achievements related to the adoption and deployment of in silico methods.Prestigious delegates from the entire in silico community will present, debate, inspire and engage with the audience to accelerate medical innovation through Computer Modeling and Simulation (CM&S).
Don’t miss this opportunity to engage with in silico leaders: mark your calendar, register today and, join us on October 10, 11 and / or 12 to be an actor of the healthcare transformation.
Academic or industry researchers and any leader involved in medical and pharmaceutical innovation;
Scientists and regulatory affairs professionals interested in digital evidence;
Clinicians and medical staff willing to understand how in silico technology can help them in their daily activities;
Patient associations keen on learning more about in silico methods, with a special focus on delivering faster safer and more affordable health care to the patient.
Why should you attend?
Learn recent advances supporting in silico methods for research, regulatory and clinical activities, on the medical device, bio/pharma and treatment fields.
Update on academic, industry and regulatory leaders’ visions and timelines for larger scale adoption of in silico medicine.
Ask questions, express concerns, debate with experts and peers about important, immediate next steps to combine health care innovation and better patient safety.
October 10th – Focus on Regulatory – «Uncovering the regulatory pathway»
14:00 - 14:05 Welcome Roberta Maggi, Office Manager, Avicenna Alliance
14:05 - 14:20 Introduction to Avicenna Alliance Thierry Marchal, Secretary General, Avicenna Alliance, Ansys
14:20 - 14:35 Introduction to the topic Cécile Rousseau, Leader of the In Silico Application WG, Master of Ceremony, Avicenna Alliance, VCLS 14:35 - 14:50 Keynote 1 Flora Musuamba, EMA 14:50 - 15:05 Keynote 2 Raj Madabushi, FDA 15:05 - 15:20 “In silico confidence: the regulatory journey for computational modeling and medical devices.“, Keynote Speaker, Pras Pathmanathan, FDA
15:20 - 15:35 BREAK
15:35 - 15:50 "Charting the Future: Unveiling the Regulatory Complexities of In Silico Trials with the Regulatory Agencies”, Francesco Pappalardo, University of Catania, Mimesis 15:50 - 16:05 “A path towards a comprehensive regulatory framework for acceptance of in silico evidence (Countries experiences)”, Martha De Cunha, Leader of the Policy Development WG, Avicenna Alliance, Edwards Lifesciences 16:05 - 16:20 "Going Towards Good Simulation Practices",Luca Emili, Chair of the GSP Task Force, InSilicoTrials 16:20 - 16:30 "Artificial intelligence-driven drug development against autoimmune diseases", Case study, Philippe Moingeon, Servier 16:30 - 16:40 ‘Scoping and Validating an In Silico Clinical Trial: A Case Study on a Shoulder Stem",’Case study, Jeff Bischoff, Zimmer Biomet 16:40 - 16:50 “In Silico Advancements in Cardiovascular Device Design and Approval”, Case study, Simon Sonntag, Virtonomy 16:50 - 17:00 "In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials", Case study, Alejandro Frangi, University of Manchester
October 11th – Focus on Research – «Building reliable models»
14:00 - 14:20 Introduction to tasks forces & community-based initiatives Liesbet Geris, Leader of Research & Technology WG, Master of Ceremony, Avicenna Alliance, VPHi
14:20 - 14:50 “Why do we need Medical Digital Twins?”, Frank Rademakers, Keynote Speaker, KU Leuven
14:50 - 15:20 "In Silico Research: Opportunities and Challenges. An industry-wide perspective", Keynote Speaker, Gordon Johnston, Chair of the AI Task Force, J&J.
15:20 - 15:50 Keynote 3 Alison Marsden, Professor, Stanford University
15:50 - 16:10 BREAK
16:10 - 16:25 "Building digital twins for complex human diseases", Anna Niarakis, Professor, University of Toulouse III - Paul Sabatier, Center of Integrative Biology, Immune Digital Twin Consortium
16:25 - 16:40 "Conception and evaluation of a biomechanical model of the lowerlimb", Antoine Perrier, Strategic and medical chief officer, Twinsight
16:40 - 16:55 "Responses of Hypertensive Virtual Population to Calcium Channel Blocker Treatment: Comparison to a Real Population", Robert Hester, Professor Emeritus, UMMC (University of Mississippi Medical Center).
16:55 - 17:00 Introduction to the round table – Liesbet Geris, Leader of Research & Technology WG, VPHi
Thierry Marchal, Secretary General, Avicenna Alliance, Ansys
October 12th – Focus on Patients / Clinicians – «Involving and serving the Patients»
14:00 - 14:05 Welcome Roberta Maggi, Office Manager, Avicenna Alliance
14:05 - 14:25 Introduction to the topic Cyrille Thinnes, Public & Patient Involvement TFL, Master of Ceremony, Avicenna Alliance, NUI Galway
14:25 - 14:45 Keynote 3 David Hoganson, Assistant in Cardiac Surgery, Department of Cardiac Surgery, Boston Children’s Hospital
14:45 - 15:05 "Person Centered Health Care”, Keynote Speaker, Daniel de Schryver, Patient Engagement & Advocacy Lead, Janssen
15:05 - 15:25 "It's not just a headache", Keynote Speaker, Pascal Derrien, CEO, Migraine Ireland
15:25 - 15:40 BREAK
15:40 - 15:55 “Patient Involvement: Myth or indisputable necessity?”, Anne Thorez, Senior Director Patient Engagement, VCLS
15:55 - 16:10 Claudio Capelli, Research Associate, University College London
16:10 - 16:25 Zita Van Horenbeeck, Social Scientist, VPHi
16:25 - 16:35 Case study 1 Robert Joyce, MS Patient Advocate, Embedded Patient Researcher, National University of Ireland, Galway
16:35 - 16:45 Case study 2 Frances Drummond, Research Manager, Breakthrough Cancer Research
16:45 - 16:55 "PPI workshop at a scientific congress - the way forward?", Case study, Marlène Mengoni, Associate Professor, University of Leeds
16:55 - 17:05 "EUPATI – enhancing patient involvement in research through education", Case study, Maria Dutarte, Executive Director, EUPATI
17:05 - 17:20 BREAK
17:20 - 18:00 Panel discussion / Round Table Speakers: Avril Kennan, CEO, Health Research Charities Ireland Steve Levine, Chair of PPI Task Force, Sr. Director of Virtual Human Modeling, Dassault Systèmes Veronica Popa, Digital Patient Engagement Manager, EURORDIS
18:00 - 18:15 Wrap up Thierry Marchal, Secretary General, Avicenna Alliance, Ansys
